Clearside Biomedical Inc. (CLSD)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.94
0.02 (2.17%)
At close: Jan 15, 2025, 2:33 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | 8.23M | 1.33M | 29.57M | 7.89M | 2.17M | 30.00K | 345.00K | 520.00K | n/a | n/a | n/a | n/a |
Cost of Revenue | 355.00K | 204.00K | 178.00K | n/a | n/a | n/a | n/a | n/a | 33.00K | n/a | n/a | n/a |
Gross Profit | 7.87M | 1.12M | 29.40M | 7.89M | 2.17M | 30.00K | 345.00K | 520.00K | -33.00K | n/a | n/a | n/a |
Operating Income | -24.84M | -30.28M | -627.00K | -17.93M | -30.30M | -82.94M | -58.41M | -25.20M | -17.32M | -9.82M | -7.24M | -3.93M |
Interest Income | n/a | 669.00K | n/a | 335.00K | 1.03M | n/a | n/a | n/a | 8.00K | 5.00K | 7.00K | 2.00K |
Pretax Income | -32.48M | -32.95M | 376.00K | -18.21M | -30.77M | -82.82M | -58.98M | -25.88M | -17.64M | -10.19M | -7.25M | -3.93M |
Net Income | -32.48M | -34.07M | 376.00K | -18.03M | -30.56M | -82.82M | -58.98M | -25.88M | -17.64M | -10.19M | -7.25M | -3.93M |
Selling & General & Admin | 11.87M | 11.77M | 11.66M | 10.76M | 16.82M | 14.68M | 9.70M | 6.26M | 6.55M | 3.13M | 2.19M | 1.57M |
Research & Development | 20.85M | 19.63M | 18.54M | 15.07M | 15.66M | 68.29M | 49.05M | 19.45M | 10.76M | 6.69M | 5.04M | 2.35M |
Other Expenses | n/a | 669.00K | 1.00M | -275.00K | -466.00K | 127.00K | -567.00K | -684.00K | n/a | n/a | n/a | n/a |
Operating Expenses | 32.72M | 31.40M | 30.20M | 25.83M | 32.48M | 82.97M | 58.75M | 25.72M | 17.32M | 9.82M | 7.24M | 3.93M |
Interest Expense | 9.36M | 3.34M | n/a | 335.00K | 1.03M | n/a | n/a | n/a | 330.00K | 371.00K | 23.00K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 182.00K | n/a |
Cost & Expenses | 33.07M | 31.60M | 30.20M | 25.83M | 32.48M | 82.97M | 58.75M | 25.72M | 17.32M | 9.82M | 7.24M | 3.93M |
Income Tax | n/a | 1.12M | -58.56K | -180.00K | -211.00K | 127.00K | -182.00K | -65.00K | 8.00K | 5.00K | 7.00K | n/a |
Shares Outstanding (Basic) | 61.81M | 60.20M | 58.49M | 46.51M | 38.17M | 30.73M | 25.31M | 13.11M | 12.27M | 12.27M | 12.27M | 842.47K |
Shares Outstanding (Diluted) | 61.81M | 60.20M | 59.91M | 46.51M | 38.17M | 30.73M | 25.31M | 13.11M | 12.27M | 12.27M | 12.27M | 842.47K |
EPS (Basic) | -0.53 | -0.57 | 0.01 | -0.39 | -0.8 | -2.69 | -2.33 | -1.97 | -1.44 | -0.83 | -0.59 | -4.67 |
EPS (Diluted) | -0.53 | -0.57 | 0.01 | -0.39 | -0.8 | -2.69 | -2.33 | -1.97 | -1.44 | -0.83 | -0.59 | -4.67 |
EBITDA | -23.06M | -29.46M | -449.00K | -17.93M | -30.09M | -82.76M | -58.23M | -25.13M | -17.26M | -9.79M | -7.22M | -3.92M |
Depreciation & Amortization | 67.00K | 145.00K | 178.00K | 180.00K | 211.00K | 189.00K | 182.00K | 65.00K | 60.00K | 33.00K | 15.00K | 7.00K |